Methanobrevibacter smithii and Bacteroides ...

2 downloads 0 Views 252KB Size Report
Sep 14, 2016 - Accepted Manuscript. Methanobrevibacter smithii and Bacteroides thetaiotaomicron cultivated from a chronic paravertebral muscle abscess.
Accepted Manuscript Methanobrevibacter smithii and Bacteroides thetaiotaomicron cultivated from a chronic paravertebral muscle abscess Vanessa Demonfort Nkamga, Romain Lotte, Pierre-Marie Roger, Michel Drancourt, Professor Raymond Ruimy PII:

S1198-743X(16)30394-9

DOI:

10.1016/j.cmi.2016.09.007

Reference:

CMI 719

To appear in:

Clinical Microbiology and Infection

Received Date: 8 August 2016 Revised Date:

14 September 2016

Accepted Date: 14 September 2016

Please cite this article as: Nkamga VD, Lotte R, Roger P-M, Drancourt M, Ruimy R, Methanobrevibacter smithii and Bacteroides thetaiotaomicron cultivated from a chronic paravertebral muscle abscess, Clinical Microbiology and Infection (2016), doi: 10.1016/j.cmi.2016.09.007. This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

ACCEPTED MANUSCRIPT 1

Methanobrevibacter smithii and Bacteroides thetaiotaomicron cultivated from a chronic

2

paravertebral muscle abscess

3

Vanessa Demonfort Nkamga1, #, Romain Lotte2, 3, 4, #, Pierre-Marie Roger5, Michel

5

Drancourt1, and Raymond Ruimy2, 3, 4,*

RI PT

4

6 1

Unité de recherche sur les maladies infectieuses tropicales et émergentes, Marseille, France

8

2

Laboratoire de bactériologie, Centre Hospitalier Universitaire de Nice, Nice, France

9

3

Université de Nice Côte d’azur, Faculté de Médecine, Nice, France

10

4

Inserm U1065, C3M, Team6, “Bacterial toxins in host pathogen interactions”, Bâtiment

11

universitaire Archimed, Nice, France.

12

5

13

Nice, France

14

#

15

*Corresponding author: Professor Raymond Ruimy

16

Laboratoire de Bactériologie

17

Centre Hospitalier Universitaire de Nice, Hôpital de l'Archet II,

18

151 route de Saint Antoine de Ginestière CS 23079 06202 Nice Cedex 3, France

19

Tel: 33 (0) 4 92 03 62 14

20

E-mail: [email protected]

21

Keys words: Abscess, Archaea, Bacteroides, Methanobrevibacter, Metronidazole,

M AN U

SC

7

Service de maladies infectieuses et tropicales, Centre Hospitalier Universitaire de Nice,

AC C

EP

TE D

equally contributing authors

Fax: 33 (0) 4 92 03 59 52

22 23 24 25 1

ACCEPTED MANUSCRIPT Sir,

27

Methanobrevibacter smithii is the main human-associated methanogenic archaea being part of

28

the vaginal, oral and gut microbiota. As a methanogen, it is capable of detoxifying molecular

29

hydrogen resulting from fermentation by anaerobes communities, into gaseous methane. To

30

date, M. smithii has been associated in human with weight gain and obesity and with colonic

31

diseases including ulcerative colitis, Crohn’s disease and colorectal cancer [1-3]. However, its

32

role in other human diseases remains controversial and might be underestimated because of

33

difficulties associated with its culture and detection. Indeed, it requires a strict anaerobic

34

atmosphere comprising up to 80% hydrogen to grow and it can be detected by specific

35

amplification and sequencing which are not routinely used in clinical laboratories.

M AN U

SC

RI PT

26

Applying specific archae 16S rRNA [4] and methyl coenzyme M reductase (mcrA)

37

gene [5] amplification on ten human internal abscesses from various origins, we detected M.

38

smithii in a paravertebral muscular abscess from a 41-year-old man. In July 2014, the patient

39

visited the emergency department of our tertiary care center for night sweats, chronic fever

40

and worsening of a lumbar round-shaped tumefaction over the previous three months.

41

Physical examination showed a right-sided and painless paravertebral tumefaction. The lesion

42

showed mild signs of inflammation and no cutaneous fistula was observed. Pelvic

43

examination showed a right lymphadenopathy of the inguinal area with no evidence of

44

tenderness or inflammation symptoms. There appeared to be no cutaneous, abdominal,

45

neurological, and cardio-vascular abnormalities upon physical examinations. Body

46

temperature was 39°C. Blood tests revealed elevated inflammation marker values including

47

C-reactive protein (75.9 mg/L) and leukocytosis (11.4 x109/L). A full-body computed

48

tomography scan and magnetic resonance imaging revealed an abscess of the right transverse

49

muscle, and the diagnosis of chronic abscess of the transverse muscle was highly suspected,

50

but a neoplastic process was not excluded. Surgical drainage of the lesion was performed and

AC C

EP

TE D

36

2

ACCEPTED MANUSCRIPT drainage fluids and biopsies were sent to the laboratory for pathological, bacteriological

52

(including slow growth bacteria and mycobacterium) and mycological analyses. An antibiotic

53

treatment consisting of amoxicillin and clavulanic acid was initiated intravenously 2 g three

54

times a day (t.i.d) for seven days, followed by oral metronidazole 500 mg t.i.d for three

55

weeks. Histopathological findings after surgery confirmed the chronic non-specific

56

granulomatous lesion with a polymorphic inflammatory infiltrate and excluded a neoplastic

57

process. Direct microscopic examination of the pus revealed Gram-negative rods and

58

leukocytes. Culture on blood agar remained sterile under aerobic atmosphere and grew

59

Bacteroides thetaiotaomicron identified by MALDI-TOF mass spectrometry (Bruker

60

Daltonics, Germany) under anaerobic atmosphere. This anaerobic Gram-negative bacillus is a

61

major component of the physiological gut flora and is an opportunistic pathogen that can be

62

involved in severe infection such as septicemia or abscesses formation from multiple body

63

part [6]. To further investigate the presence of methanogenic archaea, the sample was

64

cultivated in SAB-medium as previously described [7]. After three-week incubation, methane

65

production was detected in tube culture. Sequencing of archaea 16S rRNA and mcrA gene

66

PCR products yielded a sequence similarity (accession number: LT223565 and LT223564) of

67

99% with the reference M. smithii ATCC 35061 homologous sequences (Figure 1). We tested

68

the susceptibility of M. smithii paravertebral strain against metronidazole and amoxicillin +

69

clavulanic acid, by transferring 500 µL of an exponentially growing culture into 4.5 mL of

70

fresh SAB-medium as previously described [8]. Briefly, two tubes of culture medium were

71

supplemented to obtain the following antibiotic concentration: metronidazole (B. Braun

72

Medical SAS, Boulogne-Billancourt, France) 1µg/mL and amoxicillin + clavulanic acid (8:1;

73

BIOGARAN, Colombes, France) 100 µg/mL. The tubes were incubated at 37°C under

74

agitation and growth of archaea was observed after 3 days of incubation. Control cultures

75

were also incubated without antibiotics to provide a baseline for growth of archaea. The

AC C

EP

TE D

M AN U

SC

RI PT

51

3

ACCEPTED MANUSCRIPT growth was monitored by measuring methane in the tubes using gas chromatography (Clarus

77

500, Perkin Elmer, Courtaboeuf, France). The isolate was resistant to amoxicillin + clavulanic

78

acid (MIC value ≥100µg/mL), and was susceptible to metronidazole (MIC value ≤1µg/mL).

79

The data reported herein was in accordance with the previous knowledge about the

80

antimicrobial susceptibility patterns of human methanogens [8]. Clinical and biological

81

follow-up at three week confirmed the complete healing of the patient.

RI PT

76

82

We isolated for the first time M. smithii in a paravertebral muscle abscess using specific

84

culture and NA-based approach for methanogens. Interestingly, B. thetaiotaomicron was

85

previously described as the major source of hydrogen needed for methanogenic archaea

86

metabolism in a humanized gnotobiotic mouse model [9]. Our study suggests that M. smithii,

87

previously known as a commensal organism, could play a role in human infections and

88

notably in chronic abscesses in association with anaerobic bacteria such as B.

89

thetaiotaomicron. We can therefore hypothesize a metabolic cooperation between these two

90

organisms. M. smithii is naturally resistant to beta-lactams which are the most used empirical

91

antibiotics to treat patients presenting with deep abscesses. Fortunately, in most cases, the

92

empirical antibiotic treatment also takes into account the presence of anaerobic bacteria and

93

includes metronidazole which is also active against methanogenic archaea. Further studies are

94

still required to precise the epidemiology of archaea in human infections and the potential

95

occurrence of resistant strains.

M AN U

TE D

EP

AC C

96

SC

83

97

Transparency declaration: All authors report no conflicts of interest for this article.

98

Acknowledgment: This work has been supported by a Grant of “Mediterranean Infection

99

Institute” (Marseille, France) to Vanessa Demonfort Nkamga, and by a grant of FRM

100

(Grant#FDM20-150632804) to Romain Lotte. 4

ACCEPTED MANUSCRIPT 101

References

102

[1]. Holma R, Korpela R, Sairanen U, Blom M, Rautio M, Poussa T et al.: Colonic methane

103

production modifies gastrointestinal toxicity associated with adjuvant 5-fluorouracil

104

chemotherapy for colorectal cancer. J Clin Gastroenterol 2013, 47: 45-51. [2]. Soares AC, Lederman HM, Fagundes-Neto U, de Morais MB: Breath methane associated with

106

slow colonic transit time in children with chronic constipation. J Clin Gastroenterol 2005,

107

39: 512-515.

cancer. Gastroenterology 1984, 87: 601-605.

109 110

[4].

[5]. Scanlan PD, Shanahan F, Marchesi JR: Human methanogen diversity and incidence in healthy and diseased colonic groups using mcrA gene analysis. BMC Microbiol 2008, 8: 79.

113 114

[6].

Wexler HM: Bacteroides the good, the bad and the Nitty-Gritty. Clin. Microbiol. Rev 2007, 20:593-621.

TE D

115 116

Lepp PW, Brinig MM, Ouverney CC, Palm K, Armitage GC, Relman DA: Methanogenic Archaea and human periodontal disease. Proc Natl Acad Sci U S A 2004, 101: 6176-6181.

111 112

SC

[3]. Pique JM, Pallares M, Cuso E, Vilar-Bonet J, Gassull MA: Methane production and colon

M AN U

108

RI PT

105

[7]. Khelaifia S, Raoult D, Drancourt M: A versatile medium for cultivating methanogenic archaea. PLoS One 2013, 8: e61563.

117

[8]. Khelaifia S, Brunel JM, Raoult D, Drancourt M: Hydrophobicity of imidazole derivatives

119

correlates with improved activity against human methanogenic archaea. Int J Antimicrob

120

Agents 2013, 41: 544-547.

122 123

[9].

AC C

121

EP

118

Samuel BS, Gordon JI: A humanized gnotobiotic mouse model of host-archaeal-bacterial mutualism. Proc Natl Acad Sci U S A 2006, 103: 10011-10016.

5

ACCEPTED MANUSCRIPT Figure 1 legend: Unrooted neighbor-joining tree based on 16S rRNA sequences showing the

125

phylogenetic position of Methanobrevibacter smithii LT223565 (paravertebral isolates)

126

within members of genera Methanobrevibacter. The tree was performed using MEGA6

127

software as previously described. Values above lines are bootstrap values expressed as

128

percentages (only values>90% are shown). Scale bar indicates accumulated changes per

129

nucleotide.

AC C

EP

TE D

M AN U

SC

RI PT

124

6

ACCEPTED MANUSCRIPT

99

RI PT

Figure 1.

Methanobrevibacter smithii AY196669 Methanobrevibacter smithii LT223565

99

SC

Methanobrevibacter smithii U55233

Methanobrevibacter oralis HE654003 Methanobrevibacter millerae AY196673

M AN U

92

Methanobrevibacter gottschalkii U55238

99

Methanobrevibacter olleyae AY615201 Methanobrevibacter ruminantium AY196666

Methanobrevibacter arboriphilus AY196665

AC C

EP

0.05

TE D

Haloferax alexandrinus NR 113438